We are live on ! Find out more
PS

Peter Svennilson Portfolio holdings

AUM $1.23B
1-Year Est. Return 301.34%
This Fund
S&P 500
This Quarter Est. Return
-9.89%
1 Year Est. Return
+301.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$322M
AUM Growth
-$28.2M
Cap. Flow
+$18.2M
Cap. Flow %
5.66%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$11.1M
2
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$7.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$224M 69.59%
16,166,907
+472,816
+3% +$7.1M
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$38.8M 12.07%
6,009,702
+1,331,763
+28% +$11.1M
RCUS icon
3
Arcus Biosciences
RCUS
$3.55B
$32.2M 10.01%
3,540,850
– –
GRTS
4
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$26.8M 8.33%
3,102,934
– –

Similar funds

CT
CGM Trust Boston, Massachusetts $957M AUM
CAW
Cornerstone Advisors (Washington) Bellevue, Washington $936M AUM 8.77% 1-Year Est. Return
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
SFSG
Stearns Financial Services Group Greensboro, North Carolina $639M AUM 11.66% 1-Year Est. Return
KFA
Kays Financial Advisory Atlanta, Georgia $624M AUM 9.93% 1-Year Est. Return
11A
10-15 Associates Goshen, New York $516M AUM 7.62% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return

Peter Svennilson's Q3 2019 Portfolio in Review

As of Q3 2019, Peter Svennilson held 4 positions worth $322M, down 8% from $350M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Peter Svennilson deployed $18.2M of net new capital in Q3 2019, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Peter Svennilson added most to Constellation Pharmaceuticals, Inc. in Q3 2019, an estimated $11.1M increase.
  • Peter Svennilson's ten largest holdings make up 100% of its $322M portfolio in Q3 2019.
  • Peter Svennilson opened 0 new positions and closed 0 in Q3 2019.
  • Peter Svennilson's portfolio value fell 8% quarter-over-quarter to $322M.

Based on Peter Svennilson's 13F filing for Q3 2019, filed 14 Nov 2019.